Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Adami, Eleonora Dr. (1) Bader, Michael Prof. Dr. (1) Birchmeier, Walter Prof. Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Gotthardt, Michael Prof. Dr. (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Kirchner, Marieluise Dr. (3) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lewin, Gary Prof. Dr. (1) Maatz, Henrike Dr. (1) Müller, Thomas Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Radke, Michael Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rajewsky, Nikolaus Prof. Dr. (3) Rother, Franziska Dr. (1) Singh, Manvendra Dr. (1) Sommer, Christian (1) Uckert, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (1) Zauber, Henrik Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (13) (-) Herzog, Margareta (1) (-) Selbach, Matthias Prof. Dr. (14) Biologie maligner Lymphome (5) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Genetik und Genomik von Herz- Kreislauferkrankungen (2) Immunregulation und Krebs (2) Mobile DNA (1) (-) Molekulare Immunologie und Gentherapie (13) Molekulare Physiologie der somatosensorischen Wahrnehmung (1) (-) Proteom Dynamik (14) RNA Biologie und Posttranscriptionale Regulation (2) Systembiologie von Gen-regulatorischen Elementen (5) Translationale Kardiologie und Funktionelle Genomforschung (1) Translationale Onkologie solider Tumore (1) Zellzustände und ihre Funktionsweisen (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) (-) 1997 (9) 1998 (9) 1999 (4) 2000 (8) 2001 (8) 2002 (8) 2003 (10) 2004 (10) 2005 (14) (-) 2006 (3) 2007 (6) 2008 (8) 2009 (8) 2010 (10) 2011 (12) 2012 (10) 2013 (15) (-) 2014 (15) 2015 (13) 2016 (12) 2017 (12) 2018 (10) 2019 (11) 2020 (6) 2021 (16) 2022 (16) 2023 (8) 2024 (4) 27 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Herzog, MargaretaSelbach, Matthias Prof. Dr.Molekulare Immunologie und Gentherapie Proteom Dynamik199720062014 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. Januar 1997 / J Immunol Influence of gene modified (IL 7, IL 4, and B7) tumor cell vaccines on tumor antigen presentation S. Cayeux G. Richter G. Noffz B. Doerken T. Blankenstein 01. Januar 1997 / Gene Ther Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells C. Lange T. Blankenstein 01. Januar 1997 / Hum Gene Ther Transient expression of SV 40 large T antigen by Cre/LoxP mediated site specific deletion in primary human tumor cells L.P. Li P.M. Schlag T. Blankenstein 01. Januar 1997 / J Immunol Down regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10 F. Salazar-Onfray J. Charo M. Petersson S. Freland G. Noffz Z.H. Qin T. Blankenstein H.G. Ljunggren R. Kiessling 16. März 2006 / Nature Robust Salmonella metabolism limits possibilities for new antimicrobials D. Becker M. Selbach C. Rollenhagen M. Ballmaier T.F. Meyer M. Mann D. Bumann 01. Dezember 2006 / Nat Methods Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK) M. Selbach M. Mann 01. Januar 1997 / Eur J Immunol Lack of correlation between rejection of tumor cells co-expressing interleukin 2 and B7.1 and vaccine efficiency S. Cayeux G. Richter C. Becker C. Beck A. Aicher A. Pezzutto B. Doerken T. Blankenstein 01. Januar 1997 / Exp Hematol Successful retroviral mediated transduction of a receptor gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells A. Aicher J. Westermann S. Cayeux G. Willimsky K. Daemen T. Blankenstein W. Uckert B. Doerken A. Pezzutto 01. Januar 1997 / Methods Mol Med Methods for use of cytokine gene-modified tumor cells in immunotherapy of cancer Z. Qin T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Januar 1997 / J Immunol Influence of gene modified (IL 7, IL 4, and B7) tumor cell vaccines on tumor antigen presentation S. Cayeux G. Richter G. Noffz B. Doerken T. Blankenstein
01. Januar 1997 / Gene Ther Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells C. Lange T. Blankenstein
01. Januar 1997 / Hum Gene Ther Transient expression of SV 40 large T antigen by Cre/LoxP mediated site specific deletion in primary human tumor cells L.P. Li P.M. Schlag T. Blankenstein
01. Januar 1997 / J Immunol Down regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10 F. Salazar-Onfray J. Charo M. Petersson S. Freland G. Noffz Z.H. Qin T. Blankenstein H.G. Ljunggren R. Kiessling
16. März 2006 / Nature Robust Salmonella metabolism limits possibilities for new antimicrobials D. Becker M. Selbach C. Rollenhagen M. Ballmaier T.F. Meyer M. Mann D. Bumann
01. Dezember 2006 / Nat Methods Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK) M. Selbach M. Mann
01. Januar 1997 / Eur J Immunol Lack of correlation between rejection of tumor cells co-expressing interleukin 2 and B7.1 and vaccine efficiency S. Cayeux G. Richter C. Becker C. Beck A. Aicher A. Pezzutto B. Doerken T. Blankenstein
01. Januar 1997 / Exp Hematol Successful retroviral mediated transduction of a receptor gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells A. Aicher J. Westermann S. Cayeux G. Willimsky K. Daemen T. Blankenstein W. Uckert B. Doerken A. Pezzutto
01. Januar 1997 / Methods Mol Med Methods for use of cytokine gene-modified tumor cells in immunotherapy of cancer Z. Qin T. Blankenstein